Jörn Aldag is a German businessperson who founded G7 Therapeutics AG and who has been at the helm of 7 different companies. Presently, Mr. Aldag occupies the position of Chairman at GeneSpire Srl and Chief Executive Officer & Director at HOOKIPA Pharma, Inc., Chief Executive Officer of Hookipa Biotech AG (a subsidiary of HOOKIPA Pharma, Inc.). Jörn Aldag is also on the board of DESERTEC Foundation, Idorsia Ltd. and Idorsia Pharmaceuticals Ltd.
In the past he occupied the position of Chairman at Molecular Partners AG, President & Chief Executive Officer for Evotec SE, Chief Executive Officer of uniQure NV and Chief Executive Officer at Amsterdam Molecular Therapeutics (AMT) Holding NV (a subsidiary of uniQure NV), Finance Director & Vice President at MAN Gutehoffnungshutte AG and Director-Business Development of Treuhandanstalt.
He received an undergraduate degree from Harvard Business School and an undergraduate degree from European Business School Group.